MOVES-China’s Hua Medicine appoints BAML banker as new CFO ahead of listing
21 Dec MOVES-China’s Hua Medicine appoints BAML banker as new CFO ahead of listing
Posted at 00:00h
in
News
by KMFSLLP
HONG KONG, Dec 22 (Reuters) – Chinese drug developer Hua
Medicine has appointed George Lin, a veteran Bank of America
Merrill Lynch banker as its chief financial officer, as
it seeks to go public in the next 12 to 18 months.
Sorry, the comment form is closed at this time.